Biomedical startup company Biome, founded by Kaunas University of Technology (KTU) researchers, is offering a synthetic bone equivalent used for bone restoration operations in odontology.
The bone equivalent Cell’in, created by Lithuanian researchers, is made from cellulose/hydroxyapatite composite. The analogical products in global market are usually created on the basis of synthetic polymers.
The bone equivalent was created by collaborating groups of researchers at KTU, headed by Professor Jolanta Liesien? (Faculty of Chemical Technology) and Lithuanian University of Health Sciences (LSMU), headed by Professor Gintaras Juodžbalis (Face and Jaw Surgery Clinic).
“The innovative bone equivalent is being created from natural polymer, i.e. cellulose. As in human body there is no cellulase, which helps to decompose cellulose, it degrades very slowly, but after some time is being resorbed. Cellulose is non-cytotoxic, biologically compatible and provides friendly environment for cell absorption and multiplication. The porosity of the implant enables the circulation of nutrients and metabolites”, said Professor Liesien?.
This means that the Cell’in bone implant would stay in place sufficiently long, so as blood vessels network can form and the bone can regrow in the place of a fraction. However, in time it will dissipate without leaving any toxic waste. Moreover, the structure of the artificial bone is completely compatible with the morphology of human bone.
Cell’in implant is an efficient solution in reducing time and price of complex dental implant surgery procedures.
Commercialised by Biome
The invention is being commercialised by a startup Biom?, which was established with the funding from Lithuanian Agency for Science, Innovation and Technology (MITA).
Biome offers an innovative approach towards production of bone equivalents: they are being produced in 3D blocks, which can be cut and shaped by a surgeon into a required size and form. Thus, the implant can fill in the whole fracture in the bone, and its macroporous matrix allows the formation of blood vessel network, which enables the growth of natural bone. After the implant dissipates, its place will be taken by a newly grown natural bone.
Established in 2014, Biome made it to TiE50 TOP Startup 2015, and was recognised as one of 50 most enterprising technology startups in the world. Every year 5 thousands of startups apply for competition from all over the world.
“To the best of our knowledge, we are the first biomedical technologies enterprise from Lithuania, which made it to the list. Now, one of our strategic tasks is finding international partners. For a small and dynamic enterprise, such partnerships are crucial”, said Kristina Lies?, director of Biome.
Although the main Biome’s project is commercialising of cellulose/hydroxyapatite composite bone, the enterprise is developing a number or other projects.
Bone restoration is the second most popular tissue transplant surgery, after bone marrow transplantation. The high demand for bone equivalent, which is used for these surgery operations, is constantly increasing.
The Latest on: Bone restoration
via Google News
The Latest on: Bone restoration
- Can 3D Printing Become the Doctor's New Tool for Repairing Broken Bones?on May 17, 2021 at 6:40 am
A process developed by researchers in Australia is simpler and less toxic than the current ways to create material suitable for human implants.
- Whale Bone Weapons Hint at World’s Earliest Coastal Economyon May 17, 2021 at 12:19 am
Thousands of years before the Neolithic Agricultural Revolution, a widespread trade network carried large whale bone spears from Spain to France.
- A spectacular gorefest – Thomas Becket: Murder and the Making of a Saint reviewon May 13, 2021 at 7:51 am
If you thought medieval religious art was all clasped hands and uplifted eyes, then prepare yourself for the gorefests that shudder through this brilliant new show like a broadsword hitting bone. On ...
- Advanced Implant Dentistry and Oral Restoration Provides Plasma Rich Growth Factors (PRGF) in Cedarhurst, NY to Maximize Healing for Dental Implantson May 12, 2021 at 3:55 am
Dr. Michael Klein and Dr. Allon Waltuch utilize Plasma Rich Growth Factors (PRGF) to maximize healing when they place dental implants in Cedarhurst, NY. PRGF is one of several advanced technologies ...
- Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cellson May 11, 2021 at 6:10 am
Aged hematopoietic stem cells (HSC) are characterised by reduced regenerative potential and a loss of quiescence. Here, the authors show nicotinamide riboside treatment shrinks the age-enlarged stem ...
- I tracked some down.on May 10, 2021 at 2:55 am
- Osteopore gets CE mark extension, significantly increases market access in Europeon May 9, 2021 at 10:10 pm
Osteopore has made progress in its expansion plans, announcing that it has received CE marking for an expanded set of products and product shelf life.
- Biden Administration’s New Gender Identity Policy Could Force Health Professionals to Violate Conscienceon May 9, 2021 at 5:00 pm
This policy is really about forcing hospitals and medical professionals to adhere to leftist ideology regarding sexuality and gender,” says Terry Schilling.
- Gloria Commits to Crafting Proposal to Restore Library Hours, a Bone of Contention in Fiscal 2022 Budget Planon May 7, 2021 at 5:48 am
Mayor Todd Gloria said Thursday he will attempt to maintain library hours – a reversal from his original proposed budget which cut services to five days a week ...
- Anika Therapeutics Inc (ANIK) Q1 2021 Earnings Call Transcripton May 7, 2021 at 1:31 am
Q1 2021 Earnings Call May 6, 2021, 5:00 p.m. ET Good evening, ladies and gentlemen, and welcome to Anika's First Quarter 2021 Earnings Conference Call. [Operator Instructions] I will now turn the call ...
via Bing News